Watanabe, H., Ichihara, E., Kayatani, H., Makimoto, G., Ninomiya, K., Nishii, K., . . . Kiura, K. (2021). VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers. Cancer Sci.
Citação norma ChicagoWatanabe, Hiromi, et al. "VEGFR2 Blockade Augments the Effects of Tyrosine Kinase Inhibitors By Inhibiting Angiogenesis and Oncogenic Signaling in Oncogene‐driven Non‐small‐cell Lung Cancers." Cancer Sci 2021.
Citação norma MLAWatanabe, Hiromi, et al. "VEGFR2 Blockade Augments the Effects of Tyrosine Kinase Inhibitors By Inhibiting Angiogenesis and Oncogenic Signaling in Oncogene‐driven Non‐small‐cell Lung Cancers." Cancer Sci 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.